CANCER TEST
PANCREATIC CANCER
HaemArray Pancreas
Information
Questions
Turn Around Time:
HaemArray Pancreas: 2 weeks*
* If the sample needs to be enriched to ensure successful results, we will contact you
I Choose
HaemArray Pancreas
With HaemArray Pancreas we focus on testing for mutations and large gene rearrangements in the BRCA1 & BRCA2 genes , whose mutations have been inextricably linked to the occurrence of hereditary pancreatic, ovarian, breast and prostate cancer.
HaemArray Pancreas analyzes an additional 13 genes (ATM, BARD1, BRIP1, CDK12, CHEK2, FANCD2, MRE11, NBN, PALB2, PPP2R2A, RAD51B, RAD54L, TP53) thus offering a comprehensive view of the degree of genetic predisposition to the following cancers: pancreatic, breast, ovarian, prostate. It is possible to test only the BRCA1 & BRCA2 genes separately .
Consult your Oncologist for the best choice and personalization for you.
Genetic testing is a personal decision made for a variety of reasons. It is also a complex decision that is best made after conversations with your family, healthcare team, and genetic counselor.
ASCO recommends that genetic testing be performed in the following cases:
- A personal or family history of cancer is an indication of a genetic (hereditary) cause of cancer.
- The test will clearly show a specific genetic change.
- The results will help diagnose or manage a condition. For example, you can take steps to reduce your risk. Steps may include surgery, medication, frequent testing, or lifestyle changes.
Mutations in the tumor suppressor genes BRCA1 & BRCA2, as well as ATM, BARD1, BRIP1, CDK12, CHEK2, FANCD2, MRE11, NBN, PALB2, PPP2R2A, RAD51B, RAD54L, TP53 account for a large number of hereditary cancer cases.
HaemArray Pancreas was developed as a method for identifying genetic mutations associated with hereditary cancers of the pancreas, ovaries, but also of the breast and prostate.
The aim is prevention and early diagnosis in the initial and more curable stages of the disease. The test can also help in choosing a treatment regimen and inform members of the wider family about the risk of developing cancer.
A small amount of blood (~10 ml) is taken, as in a routine hematology test. In the event that the blood collection is not performed at Microdiagnostics facilities, the blood should be collected in a 10ml EDTA blood collection vial.
Transport conditions: The vial with the blood is kept at refrigerator temperature (preservation) and after collection, it is recommended to be transported at Microdiagnostics facilities as soon as possible.
Contact us immediately to arrange for its safe and rapid transport to our laboratory. You will also need to quickly and easily complete the Consent Form.
In our fully integrated Laboratory, we handle your sample in such a way as to minimize unnecessary waste and time:
- The paraffin cube is placed, if possible, once on the microtome for obtaining tissue sections, by experienced tissue technologists.
- Tissue sections are obtained sequentially in such a way as to ensure diagnosis and perform Immunohistochemistry if required.
- Ensuring preservation of tissue sections for further molecular testing.
- Pathologists perform microdissection to ensure the maximum amount of cancer cells possible, removing all other necrotic cells or normal tissue that could affect the validity of the results.
- The molecular biologist immediately processes the tissue in a fully controlled environment, using next-generation sequencing (NGS) or real-time polymerase chain reaction (Real-time PCR) to identify mutations in the genes of interest.
Frequently Asked Questions (FAQ)
Mutations in the tumor suppressor genes BRCA1 & BRCA2, as well as ATM, BARD1, BRIP1, CDK12, CHEK2, FANCD2, MRE11, NBN, PALB2, PPP2R2A, RAD51B, RAD54L, TP53 account for a large number of hereditary cancer cases.
HaemArray Prostate was developed as a method for identifying genetic mutations associated with hereditary cancers of the prostate, ovaries, but also of the breast and pancreas.
The aim is prevention and early diagnosis in the initial and more curable stages of the disease. The test can also help in choosing a treatment regimen and inform members of the wider family about the risk of developing cancer.
A small amount of blood (~10 ml) is taken, as in a routine hematology test. In the event that the blood collection is not performed at Microdiagnostics facilities, the blood should be collected in a 10ml EDTA blood collection vial.
Transport conditions: The vial with the blood is kept at refrigerator temperature (preservation) and after collection, it is recommended to be transported at Microdiagnostics facilities as soon as possible.
Contact us immediately to arrange for its safe and rapid transport to our laboratory. You will also need to quickly and easily complete the Consent Form.
Contact us at 2310 23 22 72 and we will immediately assist you in quickly transporting the sample to our laboratory.
By cash, bank deposit, using a bank card or by online interbank deposit.
One of the primary concerns at Microdiagnostics is the protection of your personal data as well as the strict observance of the conditions for the protection of your genetic material and medical results.
In full compliance with the General Data Protection Regulation (GDPR), we ensure that any test conducted is done with your knowledge and consent and we do not communicate results over the phone.